All In Biotech

Drug Trial Radar · NCT00198562

Hypertension Control Based on Home Blood Pressure

Hypertension Control Based on Home Systolic Pressure Study (HOSP Study)

Last checked: Nov 19, 2026Latest source record: Apr 22, 2008 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 2,600 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

2,600

Planned (sponsor's estimate)

Start

Apr 2000

Primary completion

Mar 2012

Study completion Mar 2012

Sponsor

Lead sponsor
Ministry of Health, Labour and Welfare, JapanGovernment (non-federal)
Sponsor type
Government (non-federal)
Collaborators
Japan Cardiovascular Research Foundation
First posted
Sep 20, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Factorial
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 40 years, up to 79 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The aim of this trial is to study the effects of antihypertensive therapy based on home systolic blood pressure (BP) with different target levels using two classes of drugs. The HOSP study is a multicenter, prospective, randomized, open, blinded endpoint study. The study subjects are 40-79 years old hypertensive patients. After a 4 weeks of baseline period, subjects are randomly assigned to (1) modest control group (morning home BP \<140 mmHg) or (2) strict control group (morning home BP \<130 mmHg), and to (a) amlodipine group or (b) losartan group. Additional antihypertensive drugs can be used if home BP is not controlled. Home BP is measured in the early morning and late evening. The participants will be followed up for 5 years.

Conditions

  • Hypertension

Interventions

  • Amlodipine, LosartanDrug

    amlodipine: 2.5-10 mg once daily for 5 years losartan: 25-100 mg once daily for 5 years

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Combined cardiovascular eventsTime frame: 5 years

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • National Cardiovascular Center

    Suita, Osaka, Japan

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.